ALGS Other | Aligos Therapeutics, Inc.

Aligos Therapeutics, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

2026-08-06: Form 10-Q; Item Shares outstanding as of 2026-08-03; As filed 6,244,558.
2026-08-06: Form 10-Q; Item Shares outstanding VotingCommonStocks as of 2026-08-03; As filed 5,444,558.
2026-08-06: Form 10-Q; Item Shares outstanding NonVotingCommonStocks as of 2026-08-03; As filed 800,000.
2026-05-07: Form 10-Q; Item Shares outstanding as of 2026-05-01; As filed 6,188,223.

Filed	Form	Item	As filed
2026-08-06	10-Q	Shares outstanding as of 2026-08-03	6,244,558
2026-08-06	10-Q	Shares outstanding VotingCommonStocks as of 2026-08-03	5,444,558
2026-08-06	10-Q	Shares outstanding NonVotingCommonStocks as of 2026-08-03	800,000
2026-05-07	10-Q	Shares outstanding as of 2026-05-01	6,188,223
2026-05-07	10-Q	Shares outstanding VotingCommonStocks as of 2026-05-01	5,388,223
2026-05-07	10-Q	Shares outstanding NonVotingCommonStocks as of 2026-05-01	800,000
2026-05-07	10-Q	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2026-03-05	10-K	Shares outstanding as of 2026-03-02	6,187,807
2026-03-05	10-K	Shares outstanding VotingCommonStocks as of 2026-03-02	5,387,807
2026-03-05	10-K	Shares outstanding NonVotingCommonStocks as of 2026-03-02	800,000
2026-03-05	10-K	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2025-11-06	10-Q	Shares outstanding as of 2025-10-31	6,153,582
2025-11-06	10-Q	Shares outstanding VotingCommonStocks as of 2025-10-31	5,353,582
2025-11-06	10-Q	Shares outstanding NonVotingCommonStocks as of 2025-10-31	4,217,432
2025-11-06	10-Q	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2025-11-06	10-Q	Emerging growth company	Yes
2025-08-06	10-Q	Shares outstanding as of 2025-07-31	6,151,374
2025-08-06	10-Q	Shares outstanding VotingCommonStocks as of 2025-07-31	5,351,374
2025-08-06	10-Q	Shares outstanding NonVotingCommonStocks as of 2025-07-31	800,000
2025-08-06	10-Q	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2025-08-06	10-Q	Emerging growth company	Yes
2025-05-06	10-Q	Shares outstanding as of 2025-05-01	6,114,801
2025-05-06	10-Q	Shares outstanding VotingCommonStocks as of 2025-05-01	5,314,801
2025-05-06	10-Q	Shares outstanding NonVotingCommonStocks as of 2025-05-01	800,000
2025-05-06	10-Q	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2025-05-06	10-Q	Emerging growth company	Yes
2025-03-10	10-K	Shares outstanding as of 2025-03-06	6,114,311
2025-03-10	10-K	Shares outstanding VotingCommonStocks as of 2025-03-06	5,314,311
2025-03-10	10-K	Shares outstanding NonVotingCommonStocks as of 2025-03-06	800,000
2025-03-10	10-K	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2025-03-10	10-K	Emerging growth company	Yes
2024-11-06	10-Q	Shares outstanding VotingCommonStocks as of 2024-11-04	3,464,199
2024-11-06	10-Q	Shares outstanding NonVotingCommonStocks as of 2024-11-04	123,693
2024-11-06	10-Q	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2024-11-06	10-Q	Emerging growth company	Yes
2024-08-06	10-Q	Shares outstanding VotingCommonStocks as of 2024-08-02	76,810,229
2024-08-06	10-Q	Shares outstanding NonVotingCommonStocks as of 2024-08-02	3,092,338
2024-08-06	10-Q	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2024-08-06	10-Q	Emerging growth company	Yes
2024-05-07	10-Q	Shares outstanding VotingCommonStocks as of 2024-05-03	75,017,589
2024-05-07	10-Q	Shares outstanding NonVotingCommonStocks as of 2024-05-03	3,092,338
2024-05-07	10-Q	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2024-05-07	10-Q	Emerging growth company	Yes
2024-03-12	10-K	Shares outstanding VotingCommonStocks as of 2024-03-08	72,576,183
2024-03-12	10-K	Shares outstanding NonVotingCommonStocks as of 2024-03-08	3,092,338
2024-03-12	10-K	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2024-03-12	10-K	Emerging growth company	Yes
2023-11-02	10-Q	Shares outstanding VotingCommonStocks as of 2023-10-31	71,839,510
2023-11-02	10-Q	Shares outstanding NonVotingCommonStocks as of 2023-10-31	3,092,338
2023-11-02	10-Q	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2023-11-02	10-Q	Emerging growth company	Yes
2023-08-03	10-Q	Shares outstanding VotingCommonStocks as of 2023-07-31	40,410,244
2023-08-03	10-Q	Shares outstanding NonVotingCommonStocks as of 2023-07-31	3,092,338
2023-08-03	10-Q	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2023-08-03	10-Q	Emerging growth company	Yes
2023-05-04	10-Q	Shares outstanding VotingCommonStocks as of 2023-05-01	39,847,751
2023-05-04	10-Q	Shares outstanding NonVotingCommonStocks as of 2023-05-01	3,092,338
2023-05-04	10-Q	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2023-05-04	10-Q	Emerging growth company	Yes
2023-03-09	10-K	Shares outstanding VotingCommonStocks as of 2023-03-06	39,847,751
2023-03-09	10-K	Shares outstanding NonVotingCommonStocks as of 2023-03-06	3,092,338
2023-03-09	10-K	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2023-03-09	10-K	Emerging growth company	Yes
2022-11-02	10-Q	Shares outstanding VotingCommonStocks as of 2022-10-28	39,723,255
2022-11-02	10-Q	Shares outstanding NonVotingCommonStocks as of 2022-10-28	3,092,338
2022-11-02	10-Q	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2022-11-02	10-Q	Emerging growth company	Yes
2022-08-04	10-Q	Shares outstanding VotingCommonStocks as of 2022-08-01	39,717,001
2022-08-04	10-Q	Shares outstanding NonVotingCommonStocks as of 2022-08-01	3,092,338
2022-08-04	10-Q	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2022-08-04	10-Q	Emerging growth company	Yes
2022-05-04	10-Q	Shares outstanding VotingCommonStocks as of 2022-04-28	39,602,857
2022-05-04	10-Q	Shares outstanding NonVotingCommonStocks as of 2022-04-28	3,092,338
2022-05-04	10-Q	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2022-05-04	10-Q	Emerging growth company	Yes
2022-03-10	10-K	Shares outstanding VotingCommonStocks as of 2022-03-04	39,601,796
2022-03-10	10-K	Shares outstanding NonVotingCommonStocks as of 2022-03-04	3,092,338
2022-03-10	10-K	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2022-03-10	10-K	Emerging growth company	Yes
2021-11-04	10-Q	Shares outstanding VotingCommonStocks as of 2021-11-01	39,523,853
2021-11-04	10-Q	Shares outstanding NonVotingCommonStocks as of 2021-11-01	3,092,338
2021-11-04	10-Q	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2021-11-04	10-Q	Emerging growth company	Yes
2021-08-05	10-Q	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2021-08-05	10-Q	Emerging growth company	Yes
2021-05-10	10-Q	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2021-05-10	10-Q	Emerging growth company	Yes
2021-05-10	10-Q	Current in its reporting	No
2021-03-23	10-K	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2021-03-23	10-K	Emerging growth company	Yes
2020-11-25	10-Q	Stock registered under Section 12(b)	Common Stock, par value, $0.0001 per share · ALGS · NASDAQ
2020-11-25	10-Q	Emerging growth company	Yes
2020-11-25	10-Q	Current in its reporting	No

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Lineage Cell Therapeutics, Inc. (LCTX)	United States	$0.241B	-10.35
Protalix BioTherapeutics, Inc. (PLX)		$0.221B	9.87
ANAVEX LIFE SCIENCES CORP. (AVXL)	United States	$0.218B	-18.37
SUTRO BIOPHARMA, INC. (STRO)	United States	$0.260B	-3.05
Alector, Inc. (ALEC)	United States	$0.213B	-1.90
Invivyd, Inc. (IVVD)	United States	$0.270B	-2.42
Compass Therapeutics, Inc. (CMPX)	United States	$0.204B	-5.35
PALISADE BIO, INC. (PALI)	United States	$0.275B	-11.41
Lexeo Therapeutics, Inc. (LXEO)	United States	$0.278B	-4.19
Protara Therapeutics, Inc. (TARA)	United States	$0.198B	-3.22